Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Watching yourself walk may speed recovery after leg-lengthening surgery

NCT ID NCT07731022

Disease control Sponsor: Istanbul Aydın University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 28, 2026 · Last updated Jul 29, 2026 · Updated 1 time

Summary

This trial tests whether adding video feedback to standard physical therapy helps people walk better after cosmetic leg-lengthening surgery. Adults aged 18 to 45 who undergo bilateral femoral lengthening will be randomly assigned to receive either conventional physiotherapy alone or a mix of conventional physiotherapy and video feedback gait training. Researchers will measure walking speed, leg function, and other outcomes before surgery and at several points during recovery.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
video feedback-supported gait training added to conventional physiotherapy
What this could lead to
If it works, this could point toward a more effective rehabilitation approach for people recovering from leg-lengthening surgery, potentially improving walking speed and function.
What could go wrong
This is a small, early-stage trial with only 32 participants, so results may not apply broadly. The video feedback adds only 10 minutes per session, so the added benefit may be modest.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 32 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Aug 2026

An estimate. Start dates often move.

Expected to finish

Nov 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 45 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Aged between 18 and 45 years * Scheduled to undergo cosmetic bilateral femoral lengthening surgery using the Lengthening Over Nail technique * Able and willing to participate regularly in the preoperative and postoperative assessments and rehabilitation program * Able to understand the study procedures and follow the physiotherapist's instructions * Willing to provide written informed consent Exclusion Criteria: * \- Presence of a congenital, neurological, or rheumatological disorder * Previous major orthopedic surgery affecting the lower extremities * Presence of cerebral palsy, muscular dystrophy, peripheral neuropathy, or another neuromuscular disorder * Advanced deformity, contracture, or osteoarthritis affecting the hip, knee, or ankle * Psychiatric illness or cognitive impairment that may affect participation or adherence * Any medical or postoperative complication preventing regular participation in the rehabilitation program * Considered unsuitable for continued participation by the treating physician or research team

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Bone lengthening are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Kinesiophobia Mobility Limitation

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Bone lengthening Gait disorders

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Private Esencan Hospital

    Istanbul, Eyalet/Yerleşke, 34517, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.